GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has been running up the charts in recent months easily surpassing $100 a share and taking charge as the biggest pot...
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) continues to trend upward in recent weeks heading back towards all-time highs of $1.20 from last year. GWPH nearly tripled in...
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) skyrocketed on Monday after the Company announced positive Phase 3 trial data for its drug Epidiolex, for the treatment of Dravet...
